Literature DB >> 8748825

Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas.

H Kawamoto1, T Uozumi, K Kawamoto, K Arita, T Yano, T Hirohata.   

Abstract

Pituitary adenomas generally are regarded as benign tumours, but a part of them can invade the cavernous sinus and recur. We examined 43 pituitary adenomas for the following factors: tumour volume, endocrinological function, cavernous sinus invasion, and growth rates examined by using anti-proliferating cell nuclear antigen (PCNA) and MIB1 (a novel anti-Ki-67) as markers. There was significant correlation between PCNA- and MIB1-positive cell rates and PCNA- and MIB1-positive cell rates were higher in the three cases with rapid regrowth than in the other cases. Staining was stronger and more distinct for MIB1 than for anti-PCNA; thus, MIB1-positive cells were easily distinguished by their intense immunoreactivity. MIB1 may be useful for detecting those rare cases with rapid regrowth even when initially regarded as benign tumours. Adenomas with cavernous sinus invasion were significantly larger than those demonstrating no invasion. However, no significant difference was found in the frequency of PCNA- or MIB1-positive cells between adenomas with and without cavernous sinus invasion. These findings suggest that cavernous sinus invasion and growth rate are independent biological factors. Therefore, cavernous sinus invasion may be due to chemical factors produced by the tumour itself rather than as a result of rapid tumour growth.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748825     DOI: 10.1007/bf01411433

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Growth rate of human pituitary adenomas.

Authors:  A M Landolt; T Shibata; P Kleihues
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

6.  Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence.

Authors:  D W Hsu; F Hakim; B M Biller; S de la Monte; N T Zervas; A Klibanski; E T Hedley-Whyte
Journal:  J Neurosurg       Date:  1993-05       Impact factor: 5.115

7.  Proliferation in pituitary adenomas: measurement by MAb KI 67.

Authors:  K Kitz; E Knosp; W T Koos; A Korn
Journal:  Acta Neurochir Suppl (Wien)       Date:  1991

8.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

9.  The occurrence of dural invasion in pituitary adenomas.

Authors:  W R Selman; E R Laws; B W Scheithauer; S M Carpenter
Journal:  J Neurosurg       Date:  1986-03       Impact factor: 5.115

10.  Numerical chromosomal aberrations in prostate cancer: correlation with morphology and cell kinetics.

Authors:  R P Henke; E Krüger; N Ayhan; D Hübner; P Hammerer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993
View more
  10 in total

1.  The clinical significance of MIB-1 labeling index in pituitary adenomas.

Authors:  Geeta Chacko; Ari G Chacko; Kalman Kovacs; Bernd W Scheithauer; Sunithi Mani; J P Muliyil; M S Seshadri
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

2.  Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.

Authors:  H Kawamoto; K Kawamoto; T Mizoue; T Uozumi; K Arita; K Kurisu
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

3.  Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas.

Authors:  W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

4.  Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas.

Authors:  H Kawamoto; T Mizoue; K Arita; A Tominaga; K Eguchi; K Kurisu
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

5.  Correlation between PCNA expression and AgNOR dots in pituitary adenomas.

Authors:  M Klencki; I Kurnatowska; D Słowińska-Klencka; A Lewiński; M Pawlikowski
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  Expression of proliferation markers in human pituitary incidentalomas.

Authors:  Masanori Suzuki; Takeo Minematsu; Kenichi Oyama; Shigeyuki Tahara; Shunsuke Miyai; Naoko Sanno; Robert Yoshiyuki Osamura; Akira Teramoto
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

7.  Proliferation markers in different types of clinically non-secreting pituitary adenomas.

Authors:  S Schreiber; W Saeger; D K Lüdecke
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

8.  Surgical results of growth hormone-secreting pituitary adenoma.

Authors:  Min-Su Kim; Hyun-Dong Jang; Oh-Lyong Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-05-31

9.  Clinical significance of Ki-67 labeling index in pituitary macroadenoma.

Authors:  Kyung-Il Paek; Seon-Hwan Kim; Shi-Hun Song; Seung-Won Choi; Hyeon-Song Koh; Jin-Young Youm; Youn Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

10.  Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.

Authors:  H Kawamoto; T Uozumi; K Kawamoto; K Arita; T Yano; T Hirohata
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.